xperienced healthcare CEO and entrepreneur bringing over 20 years of experience in the management of R&D projects in the biomedical industry. Current CEO and Founder of JaxBio, leading the advancement of early cancer diagnosis through fast, affordable, and highly sensitive blood tests. Proven experience in epigenetic-based cancer diagnostics, including executing the development of the JaxBio technology. Previously served as a CEO of D.N.S Cantek and COO at Cantek Global in the medical cannabis industry. Holds a Ph.D. in Cancer Biology from Bar Ilan University, Israel with published papers in peer-reviewed journals.